Stock NTBL NOTABLE LABS, LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Notable Labs, Ltd.

Equities

NTBL

IL0012002452

Biotechnology & Medical Research

Real-time Estimate Cboe BZX
Other stock markets
 03:53:47 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.98 USD +2.07% Intraday chart for Notable Labs, Ltd. -1.02% -49.20%
Apr. 15 Chardan Cuts Price Target on Notable Labs to $7 From $9, Keeps Buy Rating MT
Apr. 15 Chardan Cuts Price Target on Notable Labs to $7 From $9 on Higher Projected Future Share Count, Keeps Buy Rating MT

Business Summary

Notable Labs Ltd, formerly Vascular Biogenics Ltd, is an Israel-based clinical-stage biopharmaceutical company committed to developing next-generation, targeted medicines for difficult-to-treat medical conditions. The Company has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The Company's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.

Number of employees: 16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,018,261 6,396,443 ( 70.93 %) 0 70.93 %

Shareholders

NameEquities%Valuation
Builders VC LLC
25.33 %
2,284,610 25.33 % 4 M $
B Capital Group Management LP
10.74 %
968,113 10.74 % 2 M $
FR Capital Holdings LP
3.015 %
271,933 3.015 % 481 321 $
Industry Ventures LLC
2.267 %
204,424 2.267 % 361 830 $
Squarepoint OPS LLC
0.3012 %
27,167 0.3012 % 48 086 $
Morgan Stanley Capital Services LLC
0.2554 %
23,032 0.2554 % 40 767 $
G1 Execution Services LLC
0.2077 %
18,735 0.2077 % 33 161 $
Samuel Backenroth
0.1663 %
15,000 0.1663 % 26 550 $
Mariner LLC (13F Subfiler)
0.1331 %
12,003 0.1331 % 21 245 $
Telemetry Investments LLC
0.1278 %
11,528 0.1278 % 20 405 $

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.9601 USD
Average target price
8 USD
Spread / Average Target
+733.25%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
NOTABLE LABS, LTD. Stock Notable Labs, Ltd.
-49.20% 8.66M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.24% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.68% 95.71B
ARGENX SE Stock argenx SE
+1.69% 22.02B
BIONTECH SE Stock BioNTech SE
-17.21% 20.9B
GENMAB A/S Stock Genmab A/S
-9.30% 17.85B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.21B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.84% 15.52B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+2.89% 13.86B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+34.33% 12.04B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. NTBL Stock
  4. Company Notable Labs, Ltd.